Kang Hu
- Molecular Biology
- Oncology top 5%
- Genetics top 5%
- Cancer Research top 10%
- Immunology
- Co-authors
- Mark W. DewhirstChuan-Yuan LiJohn C. BellJennifer L. LanzenP. Charles LinRod D. BraunSiqing ShanQian Huang
- Topics
- Virus-based gene therapy research (5 papers)Cancer-related gene regulation (4 papers)CAR-T cell therapy research (3 papers)
- Cited by
- OncologyGeneticsBiotechnology
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Kang Hu
25 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 104
- Molecular Biology 618
- Oncology 536
- Genetics 532
- Cancer Research 245
- Immunology 216
Countries citing papers authored by Kang Hu
This map shows the geographic impact of Kang Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang Hu more than expected).
Fields of papers citing papers by Kang Hu
This network shows the impact of papers produced by Kang Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang Hu. The network helps show where Kang Hu may publish in the future.
Co-authorship network of co-authors of Kang Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Kang Hu. A scholar is included among the top collaborators of Kang Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kang Hu. Kang Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 28 | |
| 4 | 18 | |
| 5 | 25 | |
| 6 | 49 | |
| 7 | 21 | |
| 8 | 23 | |
| 9 | 0 | |
| 10 | 13 | |
| 11 | 31 | |
| 12 | 120 | |
| 13 | 224 | |
| 14 | 77 | |
| 15 | 60 | |
| 16 | 4 | |
| 17 | 14 | |
| 18 | 268 | |
| 19 | 48 | |
| 20 | 45 |
About Kang Hu
Kang Hu is a scholar working on Cancer Research, Biotechnology and Oncology, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (5 papers), Cancer-related gene regulation (4 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Oncology (536 citations), Genetics (532 citations) and Biotechnology (157 citations). Kang Hu has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Mark W. Dewhirst, Chuan-Yuan Li, John C. Bell, Jennifer L. Lanzen, P. Charles Lin, Rod D. Braun, Siqing Shan, Qian Huang, Chao Ma and Theresa Falls. Their work appears in journals such as PLoS ONE, Analytical Chemistry and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.